97 related articles for article (PubMed ID: 22266973)
1. Hepatic Fibrosis in a Long-term Murine Model of Sepsis.
Gonnert FA; Kunisch E; Gajda M; Lambeck S; Weber M; Claus RA; Bauer M; Kinne RW
Shock; 2012 Apr; 37(4):399-407. PubMed ID: 22266973
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of hepatic stellate cells, collagen types I and III synthesis and gene expression of selected cytokines during hepatic fibrogenesis following Mesocestoides vogae (Cestoda) infection in mice.
Hrckova G; Velebný S; Solár P
Int J Parasitol; 2010 Feb; 40(2):163-74. PubMed ID: 19631650
[TBL] [Abstract][Full Text] [Related]
3. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.
Ogawa T; Enomoto M; Fujii H; Sekiya Y; Yoshizato K; Ikeda K; Kawada N
Gut; 2012 Nov; 61(11):1600-9. PubMed ID: 22267590
[TBL] [Abstract][Full Text] [Related]
5. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.
Trebicka J; Racz I; Siegmund SV; Cara E; Granzow M; Schierwagen R; Klein S; Wojtalla A; Hennenberg M; Huss S; Fischer HP; Heller J; Zimmer A; Sauerbruch T
Liver Int; 2011 Jul; 31(6):860-70. PubMed ID: 21645218
[TBL] [Abstract][Full Text] [Related]
6. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP
Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
[TBL] [Abstract][Full Text] [Related]
7. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E
Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457
[TBL] [Abstract][Full Text] [Related]
8. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
9. GFAP expression in the liver as an early marker of stellate cells activation.
Morini S; Carotti S; Carpino G; Franchitto A; Corradini SG; Merli M; Gaudio E
Ital J Anat Embryol; 2005; 110(4):193-207. PubMed ID: 16536051
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats.
Abramovitch S; Dahan-Bachar L; Sharvit E; Weisman Y; Ben Tov A; Brazowski E; Reif S
Gut; 2011 Dec; 60(12):1728-37. PubMed ID: 21816960
[TBL] [Abstract][Full Text] [Related]
11. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.
Canbay A; Feldstein A; Baskin-Bey E; Bronk SF; Gores GJ
J Pharmacol Exp Ther; 2004 Mar; 308(3):1191-6. PubMed ID: 14617689
[TBL] [Abstract][Full Text] [Related]
12. Involvement of STAT3-regulated hepatic soluble factors in attenuation of stellate cell activity and liver fibrogenesis in mice.
Shigekawa M; Takehara T; Kodama T; Hikita H; Shimizu S; Li W; Miyagi T; Hosui A; Tatsumi T; Ishida H; Kanto T; Hiramatsu N; Hayashi N
Biochem Biophys Res Commun; 2011 Mar; 406(4):614-20. PubMed ID: 21356197
[TBL] [Abstract][Full Text] [Related]
13. Endogenous alpha-calcitonin gene-related peptide mitigates liver fibrosis in chronic hepatitis induced by repeated administration of concanavalin A.
Kamiyoshi A; Sakurai T; Ichikawa-Shindo Y; Iinuma N; Kawate H; Yoshizawa T; Koyama T; Muto S; Shindo T
Liver Int; 2009 May; 29(5):642-9. PubMed ID: 18673438
[TBL] [Abstract][Full Text] [Related]
14. A contributory role for activated hepatic stellate cells in the dynamics of Schistosoma japonicum egg-induced fibrosis.
Bartley PB; Ramm GA; Jones MK; Ruddell RG; Li Y; McManus DP
Int J Parasitol; 2006 Aug; 36(9):993-1001. PubMed ID: 16806222
[TBL] [Abstract][Full Text] [Related]
15. Cocktail therapy with a combination of interferon, ribavirin and angiotensin-II type 1 receptor blocker attenuates murine liver fibrosis development.
Yoshiji H; Noguchi R; Ikenaka Y; Kaji K; Aihara Y; Shirai Y; Yoshii J; Yanase K; Fukui H
Int J Mol Med; 2011 Jul; 28(1):81-8. PubMed ID: 21455560
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of human amnion epithelial cells reduces hepatic fibrosis in immunocompetent CCl₄-treated mice.
Manuelpillai U; Tchongue J; Lourensz D; Vaghjiani V; Samuel CS; Liu A; Williams ED; Sievert W
Cell Transplant; 2010; 19(9):1157-68. PubMed ID: 20447339
[TBL] [Abstract][Full Text] [Related]
17. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
Teratani T; Tomita K; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Tominaga S; Hiroi S; Irie R; Okada Y; Kurihara C; Ebinuma H; Saito H; Hokari R; Sugiyama K; Kanai T; Miura S; Hibi T
Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
[TBL] [Abstract][Full Text] [Related]
18. Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice.
Choi SS; Sicklick JK; Ma Q; Yang L; Huang J; Qi Y; Chen W; Li YX; Goldschmidt-Clermont PJ; Diehl AM
Hepatology; 2006 Nov; 44(5):1267-77. PubMed ID: 17058265
[TBL] [Abstract][Full Text] [Related]
19. Liver fibrosis in elderly cadavers: localization of collagen types I, III, and IV, α-smooth muscle actin, and elastic fibers.
Mak KM; Chu E; Lau KH; Kwong AJ
Anat Rec (Hoboken); 2012 Jul; 295(7):1159-67. PubMed ID: 22644959
[TBL] [Abstract][Full Text] [Related]
20. Hepatic alpha-smooth muscle actin expression in hepatitis C patients before and after interferon therapy.
Khan MA; Poulos JE; Brunt EM; Li L; Solomon H; Britton RS; Bacon BR; Di Bisceglie AM
Hepatogastroenterology; 2001; 48(37):212-5. PubMed ID: 11268968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
